BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1374089)

  • 21. Choriocarcinoma in a patient with human immunodeficiency virus: case presentation and review of the literature.
    Ashley I
    Mt Sinai J Med; 2002 Oct; 69(5):334-7. PubMed ID: 12415328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Massive feto-maternal hemorrhage. Diagnosis, quantitation, etiology and (para-clinical findings)].
    Povlsen JV; Jørgensen J
    Ugeskr Laeger; 1989 Mar; 151(10):618-21. PubMed ID: 2922828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metastases of gestational choriocarcinoma].
    Diadhiou F; Moreau JC; Diallo D; Diouf A; Komongui G
    Dakar Med; 1989; 34(1-4):149-52. PubMed ID: 2491374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement in survival from choriocarcinoma in Harare.
    Spooner SF; Coulombier DM
    Cent Afr J Med; 1991 Aug; 37(8):229-34. PubMed ID: 1725504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR; Brewer JI
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live birth following treatment of post molar choriocarcinoma.
    Gurung G; Ojha N; Amatya A; Shrestha I; Kc N; Poudel S; Rana A
    Nepal Med Coll J; 2009 Mar; 11(1):66-8. PubMed ID: 19769244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human immunodeficiency virus in gestational trophoblastic neoplasias--is it a poor prognostic risk factor.
    Ojwang SB; Otieno MR; Khan KS
    East Afr Med J; 1992 Nov; 69(11):647-8. PubMed ID: 1284342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Massive feto-maternal hemorrhage: an early presentation of women with gestational choriocarcinoma.
    Lam CM; Wong SF; Lee KW; Ho LC; Yu VS
    Acta Obstet Gynecol Scand; 2002 Jun; 81(6):573-6. PubMed ID: 12047317
    [No Abstract]   [Full Text] [Related]  

  • 31. Determination of hCG in choriocarcinoma using RIA kits for hCG and hCG-beta.
    Vlachová J; Růzková M; Jakoubková J; Skrivan J; Zavadil M
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():166-71. PubMed ID: 6211046
    [No Abstract]   [Full Text] [Related]  

  • 32. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraplacental choriocarcinoma coexisting with fetomaternal hemorrhage: Case report, chemotherapy management, and literature review.
    She Q; Cheng Z; El-Chaar D; Luo F; Guo X; Wen SW
    Medicine (Baltimore); 2018 Apr; 97(14):e9977. PubMed ID: 29620671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic choriocarcinoma presenting and treated during viable pregnancy: a case report.
    Bircher C; Smith RP; Seckl MJ; Brown D; Short D; Rees H; McCarthy A; Nirmal DM
    BJOG; 2011 Dec; 118(13):1672-5. PubMed ID: 21790953
    [No Abstract]   [Full Text] [Related]  

  • 35. High-risk metastatic gestational trophoblastic disease.
    Gordon AN; Gershenson DM; Copeland LJ; Saul PB; Kavanagh JJ; Edwards CL
    Obstet Gynecol; 1985 Apr; 65(4):550-6. PubMed ID: 2580255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraplacental choriocarcinoma as an unexpected cause of intrauterine death at term.
    Nagel HT; Vandenbussche FP; Smit VT; Wasser MN; Peters AA
    Int J Gynecol Cancer; 2007; 17(6):1337-9. PubMed ID: 17511805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The utility of radioimmunoassay of serum human chorionic gonadotropin in the management of choriocarcinoma.
    Gupta SK; Buckshee K; Talwar GP
    J Assoc Physicians India; 1985 Feb; 33(2):144-7. PubMed ID: 2581931
    [No Abstract]   [Full Text] [Related]  

  • 38. [Factors related to recurrence of choriocarcinoma and evaluation of treatment outcomes].
    Sun Y; Xiang Y; Wan XR; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):329-32. PubMed ID: 16762190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Choriocarcinoma after a normal pregnancy. A case report observed in Brazzaville].
    Iloki LH; Gbala-Sapoulou MV; Kocko I
    Med Trop (Mars); 1996; 56(2):170-2. PubMed ID: 8926880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between plasma levels of human chorionic gonadotropin and tumor growth during chemotherapy for human choriocarcinoma maintained in the hamster cheek pouch.
    Knecht M; Hertz R
    Cancer Treat Rep; 1978 Dec; 62(12):2101-3. PubMed ID: 571763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.